Life360, Inc. Chief Financial Officer Russell John Burke reported an option exercise and updated share holdings. On 01/14/2026, he exercised a stock option to acquire 12,427 shares of common stock at $3.58 per share, bringing his directly held common stock (including awards) to 84,657 shares. This direct position includes 72,230 restricted stock units, each representing a contingent right to one share upon vesting. He also reports 91,077 common shares held indirectly by the Russell John Burke Revocable Trust following a transfer of 18,524 directly held shares that was exempt from Section 16 under Rule 16a-13. After the transaction, a fully vested and exercisable stock option covering 419,087 shares of common stock remains outstanding.
Charles J. Prober, a director of Life360, Inc. (LIF), reported transactions on 09/15/2025 conducted under a Rule 10b5-1 trading plan. The Form 4 shows an acquisition of 7,930 shares via exercise of stock options at an $11.18 exercise price and a contemporaneous sale of 7,930 shares at $100.24 per share. After the transactions the reporting person’s direct beneficial ownership is reported as 105,456 shares in one line and 111,020 options-related shares in the derivative table; the filing also notes total holdings include 2,036 restricted stock units that convert to common stock upon vesting. The Form 4 states the 10b5-1 plan was adopted on March 14, 2025, and the option vesting schedule is described in the filing.
Life360, Inc. submitted a Rule 144 notice proposing the sale of 7,930 common shares through Fidelity Brokerage Services on 09/15/2025 with an aggregate market value of $794,903.20. The filing reports 77,548,651 shares outstanding. The securities were acquired on 09/15/2025 as options originally granted on 04/12/2022 and the stated payment method is cash. The form also discloses two prior sales by Charles Prober within the past three months: 7,930 shares sold on 07/14/2025 for $510,771.30 and 7,930 shares sold on 08/13/2025 for $667,150.90. The filer attests there is no undisclosed material adverse information.